AQUACIPRO

This brand name is authorized in Nigeria.

Active ingredients

The drug AQUACIPRO contains one active pharmaceutical ingredient (API):

1	Ciprofloxacin UNII 4BA73M5E37 - CIPROFLOXACIN HYDROCHLORIDE
	Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.
	Read more about Ciprofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-5795	Tablet	AQUACIPRO TABLETS 500MG TAB 500 mg 1 X 10	26 RNW-PP-240981 AQUACIPRO TABLETS 500MG CIPROFLOXACIN CIPROFLOXACIN HYDROCHLORIDE USP 500MG. EXCIPIENTS q.s B4-5795 Drugs Imported Products 1X10 Prescription Only Medicine (POM) 2/1/2022 PINNACLE HEALTH PHARMACEUTICAL & STORES LTD, 16/18, Nuru Oniwo Street, Aguda, Surulere, Lagos 8034707350 phppharma@yahoo.com GLOBELA PHARMA PVT. LTD., 357,G.I.D.C,SACHIN, DIST. SURAT-394230. GUJARAT STATE, INDIA, India	28/09/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA02	Ciprofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-5795